| Gonzalez, Maria Jesus |
| Active, not recruiting | 4 | 50 | Europe, RoW | Darvadstrocel, Alofisel, Cx601 | Takeda, Takeda Development Center Americas, Inc. | Crohn's Disease, Complex Perianal Fistula | 03/26 | 03/26 | | |
NCT05357989 / 2022-001542-38: A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD |
|
|
| Completed | 3 | 523 | Europe, US | buntanetap/posiphen, Posiphen Tartrate, ANVS401, Placebo | Annovis Bio Inc., TFS Trial Form Support | Parkinson's Disease, Idiopathic | 12/23 | 12/23 | | |
NCT06608641: Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients |
|
|
| Recruiting | 3 | 490 | US | Endoxifen enteric-coated tablet (8 mg), Placebo Tablets | Jina Pharmaceuticals Inc., Novum Pharmaceutical Research Services | Bipolar 1 Disorder | 06/25 | 09/25 | | |
| Recruiting | 2 | 70 | Europe | Ascorbic acid, Vitamin C, 0.9% Saline solution, Saline | Hospital Universitario Ramon y Cajal | Liver Transplantation, Postreperfusion Syndrome, Ascorbic Acid | 06/23 | 07/23 | | |
NCT04845178: Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults |
|
|
| Completed | 2 | 797 | NA | ABP-450, prabotulinumtoxinA, Placebo, 0.9% sodium chloride, saline | AEON Biopharma, Inc., PPD | Migraine | 06/24 | 08/24 | | |
| Recruiting | 2 | 218 | Europe, RoW | Ipilimumab, Yervoy, Nivolumab, Opdivo, Stereotactic Radiotherapy, Salvage therapy | Melanoma Institute Australia, Bristol-Myers Squibb | Melanoma Stage Iv | 08/26 | 08/29 | | |
| Recruiting | 2 | 68 | Europe | Adagrasib | ETOP IBCSG Partners Foundation, Mirati Therapeutics Inc. | NSCLC Stage IV, KRAS P.G12C | 10/25 | 03/26 | | |
STX-001-01, NCT06249048: Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab |
|
|
| Recruiting | 1/2 | 108 | US, RoW | STX-001, Keytruda®, Pembrolizumab | Strand Therapeutics Inc. | Advanced Solid Tumor | 05/27 | 11/28 | | |
NCT06545435: Predicting Appendicular Lean and Fat Mass With Bioelectrical Impedance Analysis Among Adult Patients With Obesity. |
|
|
| Recruiting | N/A | 400 | Europe, Canada, US, RoW | | University of Roma La Sapienza, University of Trieste, University of North Carolina, Chapel Hill, Federal University of Pelotas, Louisiana State University Health Sciences Center in New Orleans, University of Cagliari, University of Lisbon, University of Alberta, Curtin University | Obesity | 06/25 | 12/25 | | |
NCT04232696: Neuspera's Implantable Sacral Nerve Stimulation System in Patients with Symptoms of Urinary Urgency Incontinence (UUI) |
|
|
| Active, not recruiting | N/A | 242 | Europe, US | Neuspera Implantable Sacral Nerve Stimulation System | Neuspera Medical, Inc. | Urinary Urgency Incontinence | 07/24 | 12/26 | | |
| Recruiting | N/A | 639 | Europe | | University Hospital, Strasbourg, France | COVID-19 | 12/23 | 12/23 | | |
| Recruiting | N/A | 80 | Europe, US | Oxygen | Boston Children's Hospital, Massachusetts General Hospital, Massachusetts Institute of Technology, National Institute for Biomedical Imaging and Bioengineering (NIBIB), Madrid-MIT M+Visión Consortium | Intrauterine Growth Restriction | 09/25 | 09/26 | | |
| Completed | N/A | 5694 | Europe | | University Hospital, Strasbourg, France | COVID-19 | 04/22 | 06/22 | | |
